Works matching IS 13866346 AND DT 2020 AND VI 50 AND IP 3
Results: 15
Zinc deficiency in patients with chronic liver disease in Japan.
- Published in:
- Hepatology Research, 2020, v. 50, n. 3, p. 396, doi. 10.1111/hepr.13465
- By:
- Publication type:
- Article
Discordance of hepatitis B vaccination policies for healthcare workers between the USA, the UK, and Germany.
- Published in:
- Hepatology Research, 2020, v. 50, n. 3, p. 272, doi. 10.1111/hepr.13470
- By:
- Publication type:
- Article
Inflammation, etiologies and Model for End‐stage Liver Disease score: What makes liver disease patients susceptible to developing colorectal neoplasia?
- Published in:
- Hepatology Research, 2020, v. 50, n. 3, p. 342, doi. 10.1111/hepr.13463
- By:
- Publication type:
- Article
Favorable outcome of retreatment by direct‐acting antivirals for hepatitis C patients with daclatasvir plus asunaprevir combination therapy failure.
- Published in:
- Hepatology Research, 2020, v. 50, n. 3, p. 303, doi. 10.1111/hepr.13462
- By:
- Publication type:
- Article
Analyses of objective response rate, progression‐free survival, and adverse events in hepatocellular carcinoma patients treated with lenvatinib: A multicenter retrospective study.
- Published in:
- Hepatology Research, 2020, v. 50, n. 3, p. 382, doi. 10.1111/hepr.13460
- By:
- Publication type:
- Article
Evaluation of muscarinic acetylcholine receptor type 3 gene polymorphisms in patients with primary biliary cholangitis and primary sclerosing cholangitis.
- Published in:
- Hepatology Research, 2020, v. 50, n. 3, p. 321, doi. 10.1111/hepr.13455
- By:
- Publication type:
- Article
Hepatocellular carcinoma occurrence does not differ between interferon‐based and interferon‐free treatment with liver histological assessment.
- Published in:
- Hepatology Research, 2020, v. 50, n. 3, p. 313, doi. 10.1111/hepr.13454
- By:
- Publication type:
- Article
Clinical utility of the Liver Frailty Index for predicting muscle atrophy in chronic liver disease patients with hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2020, v. 50, n. 3, p. 330, doi. 10.1111/hepr.13453
- By:
- Publication type:
- Article
Favorable radiological antitumor response at 2 weeks after starting lenvatinib for patients with advanced hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2020, v. 50, n. 3, p. 374, doi. 10.1111/hepr.13452
- By:
- Publication type:
- Article
Early changes in tubular dysfunction markers and phosphorus metabolism regulators as a result of switching from entecavir to tenofovir alafenamide fumarate nucleoside analog therapy for chronic hepatitis B patients.
- Published in:
- Hepatology Research, 2020, v. 50, n. 3, p. 402, doi. 10.1111/hepr.13451
- By:
- Publication type:
- Article
Molecular signature of hepatitis B virus regulation by interferon‐γ in primary human hepatocytes.
- Published in:
- Hepatology Research, 2020, v. 50, n. 3, p. 292, doi. 10.1111/hepr.13450
- By:
- Publication type:
- Article
Anti‐viral effects of interferon‐λ3 on hepatitis B virus infection in cell culture.
- Published in:
- Hepatology Research, 2020, v. 50, n. 3, p. 283, doi. 10.1111/hepr.13449
- By:
- Publication type:
- Article
Hypovascular hepatic nodules as a predictive factor for transcatheter arterial chemoembolization refractoriness in hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2020, v. 50, n. 3, p. 365, doi. 10.1111/hepr.13446
- By:
- Publication type:
- Article
Activation of extracellular signal‐regulated kinase is associated with hepatocellular carcinoma with aggressive phenotypes.
- Published in:
- Hepatology Research, 2020, v. 50, n. 3, p. 353, doi. 10.1111/hepr.13445
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Hepatology Research, 2020, v. 50, n. 3, p. 269, doi. 10.1111/hepr.13368
- Publication type:
- Article